Mother’s pain as three-year-old daughter’s squint turns out to be a deadly brain disease that kills most children before they turn five

Mother’s pain as three-year-old daughter’s squint turns out to be a deadly brain disease that kills most children before they turn five

A heartbroken mother spoke today about the fate of her toddler with a debilitating brain disorder that usually kills young children by the time they turn five.

Three-year-old Nellie Oakshott, from Brighton, was a “healthy” baby and was developing as expected before her diagnosis.

But in May 2022, when she was just one year old, Nellie’s mother, Megan Gillett, noticed she was blinking and having trouble walking, so she took her to the doctor.

Ms Gillett (35) and her partner Tom Oakshott (39) suspected she had cerebral palsy. Doctors diagnosed the toddler with metachromatic leukodystrophy (MLD).

The incurable brain disease, which affects one in 40,000 babies, is slowly damaged the nervous system and organs, leading to loss of physical and mental abilities.

The couple have now vowed to “find the joy in everyday life”, make the most of the time they have with their daughter and “keep living – and not focus on those who die”.

Three-year-old Nellie Oakshott from Brighton was a “healthy” baby and was developing as expected. But in May 2022, when she was just a year old, her mother, Megan Gillett, noticed that she was squinting and had trouble walking, so she took her to the doctor. In the photo Nellie with mother Megan

Ms Gillett (35) and her partner Tom Oakshott (39) suspected she had cerebral palsy.  But doctors diagnosed the toddler with metachromatic leukodystrophy (MLD).  The brain disorder, which affects one in 40,000 babies and has no cure, damages the nervous system and organs and causes loss of physical and mental abilities.  In the photo Megan and Tom with Nellie

Ms Gillett (35) and her partner Tom Oakshott (39) suspected she had cerebral palsy. But doctors diagnosed the toddler with metachromatic leukodystrophy (MLD). The brain disorder, which affects one in 40,000 babies and has no cure, damages the nervous system and organs and causes loss of physical and mental abilities. In the photo Megan and Tom with Nellie

Nellie's parents have now vowed to

Nellie’s parents have now vowed to “find the joy in everyday life”, to make the most of the time they have with their daughter and to “keep living – and not focus on those who die “. Nellie’s brother, five-month-old Ozzy, has since tested negative for MLD. In the photo Nellie with brother Ozzy

Ms Gillett, a private banker, said: “Within a few months, Nellie went from being an able child – although she couldn’t walk – to a person who couldn’t do anything at all.”

“It was heartbreaking.

“I don’t want people to think that a diagnosis always means the end.”

“We try to stay alive and not focus on the dying.” I don’t want to be sad all the time and I want to find joy in everyday life.

“She may have lost everything, but to me she is still magical.”

MLD is an inherited disease caused by an abnormal build-up of substances called sulfatides in nerve cells, particularly in the white matter of the brain.

Sulfatides are normally broken down and removed from the body by an enzyme called arylsulfatase A. But the gene responsible for producing this enzyme is defective in people with ALS.

This causes sulfatides to block the transmission of vital messages between nerves.

In England, around four children are born with MLD each year.

The first symptoms appear between the ages of six months and two years and include hanging and the child not developing as expected.

Over time, young people lose understanding and awareness of their surroundings, have seizures and can no longer chew or swallow.

Children whose MLD begins before 30 months of age – the most common and rapidly progressive form – typically have a life expectancy of between five and eight months.

Ms Gillett, a private banker, said:

Ms Gillett, a private banker, said: “Within a few months, Nellie went from being an able child – although she couldn’t walk – to a person who couldn’t do anything at all. “It was heartbreaking. “I don’t want people to think that a diagnosis always means the end.” “We try to stay alive and not focus on the dying.” I don’t want it to always be sad, find the joy in everyday life.

A JustGiving crowdfunder campaign was launched to raise money for Nellie's hospice, Chestnut Tree House Children's Hospice.  More than £2,000 has been raised since August.  In the photo Nellie with Tom

A JustGiving crowdfunder campaign was launched to raise money for Nellie’s hospice, Chestnut Tree House Children’s Hospice. More than £2,000 has been raised since August. In the photo Nellie with Tom

Data show that those whose MLD starts later have a 10 to 20 year longer life expectancy.

Nellie’s brother, five-month-old Ozzy, has since tested negative for MLD.

Ms Gillett was told by doctors that Nellie needed hospice care.

She said: “It was absolutely terrible to receive the news that Nellie’s life was going to be cut short.”

“They put us in a room and told us the only treatment available was hospice.”

She added: “We stopped working and had a great summer with everything we wanted – Peppa Pig parties, festivals, static caravan holidays, constant trips.”

“We don’t want to be sad.” When she is gone, we can be sad. She is still there and can laugh.

“There is much more to do, such as swimming, interacting with animals, music days, racing cars and playgroups.”

“Our hospice nurse Emma Sharp is an angel and helped Nellie discover her inner adrenaline junkie, with skiing, ziplining and speed boating in her schedule.”

A JustGiving crowdfunder campaign was launched to raise money for Nellie’s hospice, Chestnut Tree House Children’s Hospice. More than £2,000 has been raised since August.

Ms Gillett and her brother Rory, 32, I also plan to rappel down Brighton’s i360 on November 24 to raise money.

Pascale Harvie, President and CEO of JustGiving, said: “I was deeply saddened to hear little Nellie’s story.

“No parent should ever have to face the possibility of losing their child, and despite everything Megan has been through, she somehow found the strength and courage to take on this challenge.

“Megan is a wonderful mother and an incredible person. I wish her luck with her rappelling.’

Teddi Shaw, now two, earlier this year became the first child on the NHS to receive revolutionary gene therapy to treat MLD – the most expensive drug the health service has ever prescribed.

She is now a healthy and happy toddler and shows no signs of the devastating disease she was born with.

What is Metachromatic Leukodystrophy (MLD)?

Metachromatic leukodystrophy (MLD) is a rare, genetic, degenerative neurometabolic disease that affects approximately one in 40,000 people (mainly children) worldwide.

It is a hereditary disease, but parents are usually not affected.

Currently, it is a disease for which there is no cure. Those affected by MLD suffer from a deficiency of the enzyme arylsulfatase A, which is responsible for breaking down fatty substances called sulfatides into harmless chemicals.

A person with MLD cannot break down these sulfatides, causing them to build up in the body.

This accumulation leads to the destruction of myelin (demyelination), the protective coating on nerve fibers that enables communication between the nerves and the brain.

There are different forms of MLD:

Late infantile: It affects children under 4 years old and is the most common form of the disease. Motor milestones and some cognitive functions are lost.

The disease progresses rapidly and death usually occurs within 5-6 years.

Early childhood: AAffects children aged 4 to 6 and manifests as a loss of motor milestones and learning and behavioral problems. Death usually occurs within 10-15 years.

Late adolescence: Children between the ages of 6 and 16 are affected. This form of MLD often manifests itself in personality and behavioral changes as well as dementia.

Adult: This form of the disease is very rare and symptoms include personality and behavioral changes combined with dementia. As with the late juvenile form, the disease progresses very slowly.

Bone marrow and stem cell transplants have been successful in slowing or stopping MLD in patients without symptoms.

In the late infantile stage, the most common and aggressive form of the disease, transplants can generally only be performed on younger siblings of patients diagnosed with MLD.

All information courtesy of the Evanosky Foundation.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Top Trending

Related POSTS